Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02898688 · ClinicalTrials.gov registry record · NA
P3+ Intervention Phase
A NA study of Vaccination, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 2,200
- Enrollment target
- 20
- Study locations
NCT02898688: Completed NA study of Vaccination, sponsored by Emory University.
NCT02898688 is a NA study of Vaccination that has completed, run by Emory University. The registered enrollment target is 2,200 participants, below the 10,050-participant average among 12 other Vaccination trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02898688, a NA study of Vaccination, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,200 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will address vaccine uptake both for pregnant women and for their children, through 20 months of age, to test the hypothesis that exposure to the P3+ intervention package will increase the likelihood a pregnant woman gets herself vaccinated against influenza and pertussis before delivery and get her child vaccinated on time. This study builds off of a prior intervention, developed by Emory, at the practice, provider, and patient levels (P3) to develop, implement and evaluate an enhanced intervention (P3+) to improve vaccination uptake among pregnant women, and later, their children.
Primary Outcome
Whether or not the participant chose to receive the flu vaccine during pregnancy (between the baseline visit and birth of infant) will be compared between study arms
Conditions Studied
Interventions
- BEHAVIORAL Control Site
- BEHAVIORAL Intervention Site
- BEHAVIORAL Patient-level Control Group
- BEHAVIORAL Patient-level Intervention Group
Study Locations (20)
Colorado
- CU Center for Midwifery - Aurora
- CU Maternal and Fetal Medicine Clinic - Aurora
- University Nurse Midwives - Aurora
- Boulder Women's Care - Boulder
- St. Joe's Midwives - Denver
- Partners in Women's Health at Rose - Denver
- Rocky Mountain OBGYN - Denver
- Colorado Mountain Medical - Edwards
- Bella Natural Women's Care - Englewood
- Associates in Women's Health - Golden
- Women's Health Group Thornton - Thornton
Georgia
- Atlanta Women's Specialists - Alpharetta
- Roswell Ob/Gyn - Alpharetta
- Athens Midwifery - Athens
- Athens Ob-Gyn - Athens
- Women's Healthcare Associates of Athens - Athens
- Emory Clinic - Atlanta
- Riverbend OB/GYN and Counseling - Atlanta
- Peachtree Women's Clinic - Cumming
- Comprehensive Women's OB/GYN - Duluth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2017-06-12 |
| Est. Completion | 2020-07-06 |
| Phase | NA |
What the finished NCT02898688 record still lists
NCT02898688 is an interventional study that assigns participants to a tested intervention. Its 2,200 participants enrollment target places it among the larger protocols in the corpus, below the 10,050-participant average among 12 other Vaccination trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Vaccination appearing as the primary indexed condition, and to 4 interventions - of which Control Site is the first listed.
NCT02898688 names 20 study sites across 2 states, led by Colorado, Georgia.
Frequently Asked Questions
What is clinical trial NCT02898688 about?
NCT02898688 is a clinical study titled "P3+ Intervention Phase". This study will address vaccine uptake both for pregnant women and for their children, through 20 months of age, to test the hypothesis that exposure to the P3+ intervention package will increase the likelihood a pregnant woman gets herself vaccinated against influenza and pertussis before delivery ...
What is the current status of trial NCT02898688?
This trial is currently completed. It is a NA study. The enrollment target is 2,200 participants. The study started on 2017-06-12. Estimated completion is 2020-07-06.
What conditions does trial NCT02898688 study?
This clinical trial studies the following conditions: Vaccination.
What interventions are being tested in trial NCT02898688?
The interventions under investigation include: Control Site (BEHAVIORAL), Intervention Site (BEHAVIORAL), Patient-level Control Group (BEHAVIORAL), Patient-level Intervention Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02898688?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02898688 being conducted?
This trial has 20 study locations across Colorado, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02898688's enrollment target sits among peer trials
2,200 5th of 12 higher than 8 of 12 other Vaccination trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaccination trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
RECRUITING · NA
-
"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
RECRUITING · NA
-
ARISe at UMass Chan
RECRUITING · NA
-
Kaiser Colorado Flu Nudge
ACTIVE NOT RECRUITING · NA
-
Text Message Reminder-Recalls For Early Childhood Vaccination
COMPLETED · NA
-
The STOP-HPV Trial 2: Performance Feedback Intervention
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI